Carrington Laboratories, Inc.
United StatesFDA applicant, unverified
- Devices
- 15
What Carrington Laboratories, Inc. makes
Carrington Laboratories, Inc. manufactures wound care dressings, including hydrogel-based dressings, gauze pads, and strips, as well as oral wound dressings and rinses for dental or mucosal applications. Their products include sterile wound dressings with antimicrobial properties, such as Carrasyn FDG pads and Carragauze strips, as well as specialized oral therapies like the Salicept oral patch and Radiacare oral wound rinse. The portfolio also covers aloe-based oral rinses and modified wound dressings tailored for specific medical uses.
These devices are classified as Class II under the FDA’s regulatory framework and are listed via the 510(k) pathway. The company’s products are registered in the FDA’s 510(k) database, adhering to U.S. medical device regulations. Carrington Laboratories, Inc. is headquartered in the United States.
Catalogue
Search and filter all 15 devicesFrequently asked questions
How many devices does Carrington Laboratories, Inc. have in the registry?
The registry currently lists 15 devices for Carrington Laboratories, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Carrington Laboratories, Inc.'s devices?
Among its 15 most recently registered devices, Carrington Laboratories, Inc. has devices listed in FDA 510(k) (15 devices).
What are the newest devices from Carrington Laboratories, Inc. in the registry?
The most recently registered devices listed for Carrington Laboratories, Inc. include CARRINGTON WOUND DRESSING, CARRASYN FDG, ALOE THERAPY ORAL RINSE and CASRRASYN ORAL WOUND DRESSING.